Systemic corticosteroids increase the risk of diabetes, but what about in patients who take high-dose inhaled corticosteroids? How do we best manage the risk-benefit equation in patients with chronic obstructive pulmonary disease (or COPD)? Dr. Christopher Slatore, assistant professor in the division of pulmonary and critical care medicine, Portland VA Medical Center / Oregon Health and Sciences University, in Portland, Oregon, discusses the association between inhaled corticosteroid use and serum glucose concentration. Dr. Mary Leuchars hosts.
Inhaled Corticosteroids and the Risks of Diabetes Onset and Progression

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Systemic corticosteroids increase the risk of diabetes, but what about in patients who take high-dose inhaled corticosteroids? How do we best manage the risk-benefit equation in patients with chronic obstructive pulmonary disease (or COPD)? Dr. Christopher Slatore, assistant professor in the division of pulmonary and critical care medicine, Portland VA Medical Center / Oregon Health and Sciences University, in Portland, Oregon, discusses the association between inhaled corticosteroid use and serum glucose concentration. Dr. Mary Leuchars hosts.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Bridging Distances in PAH: Bringing Best Practices to the People Through Telementoring
Updates From the 7th World Symposium Task Force
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
HF Management for Patients with Comorbid Conditions
Pulmonary Hypertension Management: Practice Trends and Updates
Evaluating Sleep Deprivation as a Risk Factor for Postpartum Depression
Clinical Strategies for Assessing Sleep Disturbances in Postpartum Patients
mIDH Gliomas Explained: Characteristics and Management Strategies
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?